XIAOMI-W
01810
POP MART
09992
BYD COMPANY
01211
4
MIXUE GROUP
02097
5
SMIC
00981
HK Stock MarketDetailed Quotes
01099 SINOPHARM
- 18.400
- +0.100+0.55%
Not Open May 9 16:08 CST
57.42BMarket Cap7.48P/E (TTM)
18.480High18.220Low3.94MVolume18.300Open18.300Pre Close72.52MTurnover0.29%Turnover Ratio7.54P/E (Static)3.12BShares23.65052wk High0.66P/B24.69BFloat Cap16.02052wk Low0.96Dividend TTM1.34BShs Float40.024Historical High0.956Dividend LFY1.42%Amplitude8.756Historical Low18.394Avg Price400Lot Size5.20%Div YieldTTM5.20%Div Yield LFY
SINOPHARM Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -28.25%14B | ---- | -14.32%7.6B | ---- | 5.11%19.51B | ---- | 10.77%8.87B | ---- | 9.18%18.56B |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | 89.00%-4.41M | ---- | 7.10%-563K | ---- | -206.83%-40.05M | ---- | -13.27%-606K | ---- | 59.20%-13.05M |
| Attributable subsidiary (profit) loss | ---- | -8.31%-1.2B | ---- | -8.78%-624.72M | ---- | -3.78%-1.11B | ---- | -16.51%-574.28M | ---- | 0.26%-1.07B |
| Impairment and provisions: | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B | ---- | -40.61%729.81M |
| -Other impairments and provisions | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M | ---- | 33.26%1.32B | ---- | -40.61%729.81M |
| Revaluation surplus: | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K | ---- | 62.88%-13.18M |
| -Other fair value changes | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M | ---- | 100.98%76K | ---- | 62.88%-13.18M |
| Asset sale loss (gain): | ---- | 11.33%2.46B | ---- | -25.42%1.3B | ---- | -57.30%2.21B | ---- | 8,808.00%1.75B | ---- | 476.41%5.17B |
| -Loss (gain) from sale of subsidiary company | ---- | 80.14%-5.51M | ---- | -88.32%-9.43M | ---- | -176.25%-27.74M | ---- | 32.50%-5.01M | ---- | 2,559.50%36.38M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 100.08%187K | ---- | 96.23%-3.39M | ---- | -1,270.30%-235.93M | ---- | -1,804.81%-89.89M | ---- | -907.43%-17.22M |
| -Loss (gain) from selling other assets | ---- | -0.33%2.46B | ---- | -28.57%1.31B | ---- | -52.02%2.47B | ---- | 23,389.04%1.84B | ---- | 472.24%5.15B |
| Depreciation and amortization: | ---- | 6.85%4.73B | ---- | 10.73%2.33B | ---- | 6.37%4.43B | ---- | 4.95%2.1B | ---- | 6.19%4.17B |
| -Depreciation | ---- | 3.16%1.91B | ---- | 14.50%941.11M | ---- | 3.94%1.86B | ---- | -4.61%821.95M | ---- | 6.92%1.79B |
| -Amortization of intangible assets | ---- | 6.22%441.81M | ---- | -17.39%208.41M | ---- | 6.47%415.93M | ---- | 41.25%252.29M | ---- | 2.35%390.66M |
| Special items | ---- | -9.26%-108.08M | ---- | 25.45%-11.13M | ---- | -1.14%-98.92M | ---- | -104.28%-14.93M | ---- | -5.33%-97.81M |
| Adjustment items | ---- | ---50M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -12.26%22.47B | ---- | -11.37%11.91B | ---- | -6.65%25.61B | ---- | 6.84%13.44B | ---- | 7.66%27.44B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -547.82%-2.04B | ---- | -45.87%-8.88B | ---- | 104.79%455.56M | ---- | -9.67%-6.09B | ---- | -118.72%-9.5B |
| Accounts receivable (increase)decrease | ---- | -16.98%-17.49B | ---- | 19.14%-57.88B | ---- | -1,578.31%-14.96B | ---- | -78.80%-71.58B | ---- | 103.86%1.01B |
| Accounts payable increase (decrease) | ---- | -111.11%-964.07M | ---- | -32.83%16.12B | ---- | -12.40%8.68B | ---- | 691.93%24B | ---- | -50.70%9.91B |
| prepayments (increase)decrease | ---- | -87.79%596.23M | ---- | -103.09%-28.8M | ---- | 165.10%4.89B | ---- | 141.16%933.46M | ---- | -6,060.39%-7.5B |
| Special items for working capital changes | ---- | 558.41%13.43B | ---- | 132.08%468.49M | ---- | -173.02%-2.93B | ---- | -528.35%-1.46B | ---- | 328.63%4.01B |
| Cash from business operations | ---- | -26.42%16B | ---- | 6.06%-38.29B | ---- | -14.25%21.75B | ---- | -27.76%-40.76B | ---- | 89.53%25.36B |
| Other taxs | ---- | 2.60%-4.46B | ---- | -5.35%-2.71B | ---- | -4.01%-4.58B | ---- | -7.46%-2.57B | ---- | -7.98%-4.4B |
| Adjustment items of business operations | 27.81%-34.28B | ---- | -20.29%-47.72B | ---- | -16.68%-47.48B | ---- | -26.22%-39.67B | ---- | -11.51%-40.69B | ---- |
| Net cash from operations | 27.81%-34.28B | -32.77%11.55B | -20.29%-47.72B | 5.38%-40.99B | -16.68%-47.48B | -18.08%17.17B | -26.22%-39.67B | -26.34%-43.33B | -11.51%-40.69B | 125.22%20.96B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -59.16%74.7M | ---- | 2.72%39.72M | ---- | 145.31%182.9M | ---- | -2.94%38.67M | ---- | -11.99%74.56M |
| Dividend received - investment | -91.29%1.09M | 76.06%738.28M | 67.00%286.4M | 309.39%245.03M | 29.46%12.54M | -25.79%419.34M | -34.28%171.5M | -40.13%59.85M | -62.27%9.68M | 29.62%565.09M |
| Restricted cash (increase) decrease | ---- | -2,579.71%-2.55B | ---- | -100.27%-4.8M | ---- | 105.83%102.91M | ---- | 54.58%1.76B | ---- | -415.16%-1.76B |
| Sale of fixed assets | -94.97%2.26M | -85.59%65.74M | -67.36%113.37M | 85.47%92.91M | 717.81%44.86M | 164.67%456.13M | 1,127.92%347.35M | 20.02%50.09M | -12.59%5.49M | 28.60%172.34M |
| Purchase of fixed assets | 32.10%-321.22M | 24.91%-1.47B | -2.26%-1.38B | -42.23%-1.02B | -16.41%-473.1M | 7.88%-1.96B | 8.18%-1.35B | 17.32%-719.37M | 5.02%-406.41M | -2.57%-2.13B |
| Selling intangible assets | ---- | -97.00%6.28M | ---- | -30.07%16.32M | ---- | 4,467.04%209.08M | ---- | 148.54%23.33M | ---- | -87.90%4.58M |
| Purchase of intangible assets | ---- | -31.98%-496.6M | ---- | -98.84%-273.35M | ---- | -29.58%-376.28M | ---- | -161.26%-137.47M | ---- | -59.79%-290.39M |
| Sale of subsidiaries | ---- | 2.17%101.35M | --11.42M | -0.74%43.87M | ---- | -15.40%99.2M | ---- | 324.06%44.19M | ---- | 533.76%117.26M |
| Acquisition of subsidiaries | ---- | -70.26%-223.13M | -126.41%-168.44M | -183.82%-103.51M | -271.22%-97.04M | 71.13%-131.05M | 28.05%-74.4M | 78.27%-36.47M | ---26.14M | 10.44%-453.97M |
| Recovery of cash from investments | -77.30%13.65M | -92.81%5.88M | 161.02%83.66M | -176.23%-71.52M | 380.39%60.16M | -61.41%81.87M | 122.57%32.05M | -32.50%93.81M | --12.52M | -29.22%212.16M |
| Cash on investment | ---- | ---- | 78.50%-19.48M | ---41K | 89.33%-4.92M | 99.58%-422K | 49.25%-90.57M | ---- | -62.76%-46.17M | -33.33%-100M |
| Other items in the investment business | 29.16%921.71M | ---- | 3.60%1.01B | ---- | -17.69%713.63M | ---28.64M | 124.68%978.9M | ---326K | 70.95%867.04M | ---- |
| Net cash from investment operations | 141.09%617.49M | -297.12%-3.75B | -578.30%-61.47M | -187.97%-1.04B | -38.43%256.12M | 73.69%-944.54M | 101.27%12.85M | 201.89%1.18B | 402.02%416.01M | -183.33%-3.59B |
| Net cash before financing | 28.73%-33.66B | -51.97%7.8B | -20.48%-47.78B | 0.27%-42.03B | -17.25%-47.23B | -6.59%16.23B | -22.24%-39.66B | -24.32%-42.15B | -10.62%-40.28B | 116.07%17.37B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -2.45%32.58B | 4.43%97.43B | -7.93%89.54B | -12.12%54.49B | -9.95%33.39B | 4.63%93.29B | 7.23%97.25B | 13.87%62.01B | 27.18%37.09B | 12.97%89.16B |
| Refund | -1.26%-18.05B | -23.76%-102.66B | 11.02%-61.9B | -1.18%-35.35B | 16.81%-17.83B | 2.07%-82.95B | 1.10%-69.57B | -6.61%-34.94B | -50.20%-21.43B | -4.74%-84.7B |
| Issuance of bonds | ---- | -27.75%9.5B | ---- | 32.23%8.99B | ---- | -23.95%13.15B | ---- | 7.94%6.8B | ---- | -17.67%17.29B |
| Interest paid - financing | ---- | -3.86%-3.32B | ---- | -1.64%-1.44B | ---- | 33.05%-3.2B | ---- | 23.17%-1.42B | ---- | -4.43%-4.78B |
| Dividends paid - financing | 47.33%-584.07M | 14.09%-4.15B | 13.65%-6.49B | 10.49%-1.01B | 5.31%-1.11B | -20.59%-4.83B | -12.67%-7.52B | -39.57%-1.13B | -14.36%-1.17B | -3.94%-4.01B |
| Absorb investment income | -78.71%12.75M | 7.94%130.45M | 55.82%147.13M | 295.28%136.78M | 330.71%59.88M | -44.51%120.85M | -48.51%94.42M | -76.43%34.6M | -78.49%13.9M | -57.14%217.81M |
| Issuance expenses and redemption of securities expenses | ---- | 42.82%-12B | ---- | 66.67%-3B | ---- | -23.43%-20.99B | ---- | -350.00%-9B | ---- | 28.68%-17B |
| Other items of the financing business | -114.09%-1.08B | 95.16%-5.71M | 50.08%-1.28B | ---- | 15.50%7.64B | -157.47%-118.13M | -166.71%-2.57B | -141.32%-33.16M | 14.14%6.61B | 79.81%-45.88M |
| Net cash from financing operations | -41.88%12.88B | -126.13%-17.29B | 13.14%20.01B | 1.20%21.55B | 4.94%22.15B | -34.26%-7.64B | -0.16%17.69B | -5.41%21.3B | 7.03%21.11B | 61.25%-5.69B |
| Effect of rate | -266.16%-1.08M | -319.13%-5.24M | -151.47%-4.76M | -33.11%3.65M | 112.76%651.16K | -79.25%2.39M | -67.16%9.25M | 0.76%5.46M | -269.17%-5.1M | 277.81%11.51M |
| Net Cash | 17.11%-20.78B | -210.55%-9.49B | -26.39%-27.77B | 1.77%-20.48B | -30.80%-25.07B | -26.51%8.58B | -49.17%-21.97B | -83.07%-20.85B | -14.87%-19.17B | 275.60%11.68B |
| Begining period cash | -14.88%54.31B | 15.55%63.81B | 15.55%63.81B | 15.55%63.81B | 14.56%63.81B | 26.86%55.22B | 26.86%55.22B | 26.86%55.22B | 27.68%55.7B | -13.25%43.53B |
| Cash at the end | -13.44%33.53B | -14.88%54.31B | 8.34%36.03B | 26.05%43.33B | 6.05%38.74B | 15.55%63.81B | 15.37%33.26B | 6.94%34.38B | 35.61%36.53B | 26.86%55.22B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Tianjian International Certified Public Accountants Limited, Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.